FDA and EMA push ahead with joint efforts to kick-start pediatric cancer drug development plans
As part of an effort to ease the processes around pediatric cancer drug development, the FDA and European Medicines Agency on Wednesday unveiled a new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
